{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T18:31:01Z","timestamp":1726511461668},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s11940-005-0014-2","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T18:57:22Z","timestamp":1181069842000},"page":"211-219","source":"Crossref","is-referenced-by-count":4,"title":["Tourette\u2019s syndrome"],"prefix":"10.1007","volume":"7","author":[{"given":"Donald L.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara D.","family":"Lipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archpsyc.1993.01820210068008","volume":"50","author":"A Apter","year":"1993","unstructured":"Apter A, Pauls DL, Bleich A, et al.: An epidemiologic study of Gilles de la Tourette\u2019s syndrome in Israel. Arch Gen Psychiatry 1993, 50:734\u2013738.","journal-title":"Arch Gen Psychiatry"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.57.8.1383","volume":"57","author":"R Kurlan","year":"2001","unstructured":"Kurlan R, McDermott MP, Deeley C, et al.: Prevalence of tics in schoolchildren and association with placement in special education. Neurology 2001, 57:1383\u20131388.","journal-title":"Neurology"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1542\/peds.110.2.331","volume":"110","author":"LA Snider","year":"2002","unstructured":"Snider LA, Seligman LD, Ketchen BR, et al.: Tics and problem behaviors in schoolchildren: prevalence, characterization, and associations. Pediatrics 2002, 110:331\u2013336.","journal-title":"Pediatrics"},{"key":"14_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/brain\/123.3.425","volume":"123","author":"MM Robertson","year":"2000","unstructured":"Robertson MM: Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123:425\u2013462. This is a detailed review of diagnostic issues and prior clinical trials.","journal-title":"Brain"},{"key":"14_CR5","doi-asserted-by":"crossref","unstructured":"Gilbert DL, Buncher CR: Assessment of scientific and ethical issues in two randomized clinical trial designs for patients with Tourette Syndrome, as a model for studies of multiple neuropsychiatric diagnoses. J Neuropsychiatry Clin Neurosci 2005; In Press. This is an analysis of limitations of single-agent, placebo-controlled clinical trials in Tourette\u2019s syndrome and assessment of the potential for alternative, multi-drug, active-comparator trials.","DOI":"10.1176\/jnp.17.3.324"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, et al.: Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998, 155:264\u2013271.","journal-title":"Am J Psychiatry"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1001\/archpedi.158.9.848","volume":"158","author":"EM Perrin","year":"2004","unstructured":"Perrin EM, Murphy ML, Casey JR, et al.: Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children?[see comment]. Arch Pediatr Adolesc Med 2004, 158:848\u2013856.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.58.4.527","volume":"58","author":"Tourette\u2019s Syndrome Study G","year":"2002","unstructured":"Tourette\u2019s Syndrome Study G: Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002, 58:527\u2013536. This is a report of an NIH-funded, multi-center, randomized, controlled trial in children with combined tics and ADHD, comparing methylphenidate, clonidine, combination of both, and placebo. All treatment groups had improved tics and\/or ADHD.","journal-title":"Neurology"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1176\/appi.ajp.158.7.1067","volume":"158","author":"L Scahill","year":"2001","unstructured":"Scahill L, Chappell PB, Kim YS, et al.: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001, 158:1067\u20131074.","journal-title":"Am J Psychiatry"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00002826-200211000-00009","volume":"25","author":"DD Cummings","year":"2002","unstructured":"Cummings DD, Singer HS, Krieger M, et al.: Neuro-psychiatric effects of guanfacine in children with mild Tourette syndrome: a pilot study. Clin Neuropharmacol 2002, 25:325\u2013332.","journal-title":"Clin Neuropharmacol"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1212\/01.WNL.0000123111.00324.BF","volume":"62","author":"MH Anca","year":"2004","unstructured":"Anca MH, Giladi N, Korczyn AD: Ropinirole in Gilles de la Tourette syndrome. Neurology 2004, 62:1626\u20131627.","journal-title":"Neurology"},{"key":"14_CR12","first-page":"402","volume":"12","author":"DA Griesemer","year":"1997","unstructured":"Griesemer DA: Pergolide in the management of Tourette syndrome. J Child Neurol 1997, 12:402\u2013403.","journal-title":"J Child Neurol"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/mds.870120320","volume":"12","author":"JF Lipinski","year":"1997","unstructured":"Lipinski JF, Sallee FR, Jackson C, et al.: Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide. Mov Disord 1997, 12:402\u2013407.","journal-title":"Mov Disord"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1212\/WNL.54.6.1310","volume":"54","author":"DL Gilbert","year":"2000","unstructured":"Gilbert DL, Sethuraman G, Sine L, et al.: Tourette syn-drome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology 2000, 54:1310\u20131315.","journal-title":"Neurology"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1212\/01.WNL.0000044058.64647.7E","volume":"60","author":"DL Gilbert","year":"2003","unstructured":"Gilbert DL, Dure L, Sethuraman G, et al.: Tic reduction with pergolide in a randomized controlled trial in children. Neurology 2003, 60:606\u2013611.","journal-title":"Neurology"},{"key":"14_CR16","first-page":"75","volume":"4","author":"D Gilbert","year":"2001","unstructured":"Gilbert D, Singer HS: Commentary: \u201cRisperidone was as effective as pimozide for Tourette\u2019s disorder.\u201d EBMH 2001, 4:75.","journal-title":"EBMH"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/archneur.60.8.1130","volume":"60","author":"L Scahill","year":"2003","unstructured":"Scahill L, Leckman JF, Schultz RT, et al.: A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003, 60:1130\u20131135.","journal-title":"Neurology"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/00004714-200202000-00006","volume":"22","author":"Y Dion","year":"2002","unstructured":"Dion Y, Annable L, Sandor P, et al.: Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002, 22:31\u201339.","journal-title":"J Clin Psychopharmacol"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4088\/JCP.v62n0111","volume":"62","author":"R Bruggeman","year":"2001","unstructured":"Bruggeman R, van DL, Buitelaar JK, et al.: Risperidone versus pimozide in Tourette\u2019s disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001, 62:50\u201356.","journal-title":"J Clin Psychiatry"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/00004583-200402000-00017","volume":"43","author":"DL Gilbert","year":"2004","unstructured":"Gilbert DL, Batterson JR, Sethuraman G, et al.: Tic reduction with risperidone vs. pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry 2004, 43:206\u2013214.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","volume":"41","author":"GR Gaffney","year":"2002","unstructured":"Gaffney GR, Perry PJ, Lund BC, et al.: Risperidone versus clonidine in the treatment of children and adolescents with Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry 2002, 41:330\u2013336.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","volume":"39","author":"FR Sallee","year":"2000","unstructured":"Sallee FR, Kurlan R, Goetz CG, et al.: Ziprasidone treatment of children and adolescents with Tourette\u2019s syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry 2000, 39:292\u2013299.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1212\/WNL.56.5.605","volume":"56","author":"C Marras","year":"2001","unstructured":"Marras C, Andrews D, Sime E, et al.: Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial.[see comment]. Neurology 2001, 56:605\u2013610.","journal-title":"Neurology"},{"key":"14_CR24","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/archneur.57.8.1190","volume":"57","author":"CH Kwak","year":"2000","unstructured":"Kwak CH, Hanna PA, Jankovic J: Botulinum toxin in the treatment of tics. Arch Neurol 2000, 57:1190\u20131193.","journal-title":"Arch Neurol"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jama.247.12.1729","volume":"247","author":"TL Lowe","year":"1982","unstructured":"Lowe TL, Cohen DJ, Detlor J, et al.: Stimulant medica-tions precipitate Tourette\u2019s syndrome. JAMA 1982, 247:1729\u20131731.","journal-title":"JAMA"},{"key":"14_CR26","doi-asserted-by":"crossref","unstructured":"Anonymous: A 14-month randomized clinical trial of treatment strategies for attention-deficit\/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999, 56:1073\u20131086. This is a report of an NIH-funded, multi-center study comparing efficacy, across multiple behavioral domains, of state-of-the-art behavioral treatment, stimulants, combined treatment, and \u201ccommunity care.\u201d","DOI":"10.1001\/archpsyc.56.12.1073"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1542\/peds.108.4.1033","volume":"108","author":"American Academy of Pediatrics","year":"2001","unstructured":"American Academy of Pediatrics. Subcommittee on Attention-Deficit\/Hyperactivity D and Committee on Quality I: Clinical practice guideline: treatment of the school-aged child with attention-deficit\/hyper-activity disorder.[see comment]. Pediatrics 2001, 108:1033\u20131044. This is The American Academy of Pediatrics\u2019 Evidence-Based, Clinical Practice Guideline for ADHD treatment.","journal-title":"Pediatrics"},{"key":"14_CR28","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1542\/peds.113.4.762","volume":"113","author":"Group MTAC","year":"2004","unstructured":"Group MTAC: National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics 2004, 113:762\u2013769. This report contains second-year, follow-up data on behavioral and growth outcomes.","journal-title":"Pediatrics"},{"key":"14_CR29","unstructured":"Coffey BJ, Allen AJ, Kurlan RM, et al.: Atomoxetine Treatment in Children with ADHD and Comorbid Tic Disorders. American Psychiatic Association Meeting, 2004."},{"key":"14_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/mds.10649","volume":"19","author":"Y Temel","year":"2004","unstructured":"Temel Y, Visser-Vandewalle V: Surgery in Tourette syndrome. Mov Disord 2004, 19:3\u201314.","journal-title":"Mov Disord"},{"key":"14_CR31","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3171\/jns.2003.99.6.1094","volume":"99","author":"V Visser-Vandewalle","year":"2003","unstructured":"Visser-Vandewalle V, Temel Y, Boon P, et al.: Chronic bilateral thalamic stimulation: a new therapeutic approach in intractable Tourette syndrome. Report of three cases. J Neurosurg 2003, 99:1094\u20131100. This is an interim report of benefits and side effects of deep brain stimulator implantation in thalamus for three individu-als with severe Tourette\u2019s syndrome with self-injurious behav-ior. There was not an immediate, miraculous resolution of symptoms, but there was benefit.","journal-title":"J Neurosurg"},{"key":"14_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1176\/appi.ajp.160.6.1175","volume":"160","author":"S Wilhelm","year":"2003","unstructured":"Wilhelm S, Deckersbach T, Coffey BJ, et al.: Habit reversal versus supportive psychotherapy for Tourette\u2019s disorder: a randomized controlled trial. Am J Psychiatry 2003, 160:1175\u20131177.","journal-title":"Am J Psychiatry"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0005-7967(03)00154-2","volume":"42","author":"CW Verdellen","year":"2004","unstructured":"Verdellen CW, Keijsers GP, Cath DC, et al.: Exposure with response prevention versus habit reversal in Tourettes\u2019s syndrome: a controlled study. Behav Res Ther 2004, 42:501\u2013511.","journal-title":"Behav Res Ther"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.292.16.1969","volume":"292","author":"The Pediatric OCD Treatment Study (POTS) Team","year":"2004","unstructured":"The Pediatric OCD Treatment Study (POTS) Team: Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents with Obsessive-Compulsive Disorder: The Pediatric OCD Treatment Study (POTS) Randomized Controlled Trial. JAMA 2004, 292:1969\u20131976.","journal-title":"JAMA"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/S0006-3223(99)00020-7","volume":"45","author":"MA Garvey","year":"1999","unstructured":"Garvey MA, Perlmutter SJ, Allen AJ, et al.: A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections. Biol Psychiatry 1999, 45:1564\u20131571.","journal-title":"Biol Psychiatry"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0140-6736(98)12297-3","volume":"354","author":"SJ Perlmutter","year":"1999","unstructured":"Perlmutter SJ, Leitman SF, Garvey MA, et al.: Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood [see comments]. Lancet 1999, 354:1153\u20131158.","journal-title":"Lancet"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000036615.25044.50","volume":"59","author":"A Munchau","year":"2002","unstructured":"Munchau A, Bloem BR, Thilo KV, et al.: Repetitive transcranial magnetic stimulation for Tourette syndrome. Neurology 2002, 59:1789\u20131791.","journal-title":"Neurology"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.wnn.0000116253.78804.3a","volume":"17","author":"JH Chae","year":"2004","unstructured":"Chae JH, Nahas Z, Wassermann E, et al.: A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette\u2019s syndrome. Cogn Behav Neurol 2004, 17:109\u2013117.","journal-title":"Cogn Behav Neurol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-005-0014-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0014-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-005-0014-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:15:48Z","timestamp":1683872148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-005-0014-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11940-005-0014-2","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}